Madeline Lemke
Sunnybrook Health Sciences Centre
15 Papers
54 Citations
Madeline Lemke is an academic researcher from Sunnybrook Health Sciences Centre. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 6, co-authored 11 publications.
Chat about Author
Papers
Pasireotide for the Prevention of Pancreatic Fistula Following Pancreaticoduodenectomy: A Cost-effectiveness Analysis.
N. Goyert,Gareth Eeson,Daniel J. Kagedan,Ramy Behman,Madeline Lemke,Julie Hallet,Nicole Mittmann,Calvin Law,Paul J. Karanicolas,Natalie G. Coburn +9 more
TL;DR: Pasireotide appears to be a cost-saving treatment following PD across a wide variation of clinical and cost scenarios.
37
Symptom clusters using the Spitzer quality of life index in patients with brain metastases--a reanalysis comparing different statistical methods.
Luluel Khan,Gemma Cramarossa,Madeline Lemke,Janet Nguyen,Liying Zhang,Emily Chen,Edward Chow +6 more
TL;DR: Symptom clusters vary with respect to occurrence, quantity, and composition based on the statistical method utilized to extract them, despite the use of an identical dataset.
23
Validation of clinical risk score for colorectal liver metastases resected in a contemporary multicenter cohort.
Paul Beamish,Madeline Lemke,Jennifer Li,Elijah Dixon,Mauro E Tun Abraham,Roberto Hernandez Alejandro,Sean Bennett,Guillaume Martel,Paul J. Karanicolas +8 more
TL;DR: The CRS remains a relevant tool for predicting long-term outcomes for patients undergoing resection of CRLM and additional factors such as the presence of extrahepatic colorectal metastatic disease and the use of intraoperative portal pedicle clamping may improve the prognostic power of the CRS.
23
Symptom clusters in patients with metastatic cancer: a literature review.
Nemica Thavarajah,Emily Chen,Liang Zeng,Gillian Bedard,Julia Di Giovanni,Madeline Lemke,Natalie Lauzon,Michelle Zhou,Dominic Chu,Edward Chow +9 more
TL;DR: There were no clusters consistently identified within all eight studies and the lack of consensus among the inter-study symptom clusters are likely due to the differences in patient population as well as study methodology.
20
A decision model and cost analysis of intra-operative cell salvage during hepatic resection
Madeline Lemke,Gareth Eeson,Yulia Lin,Jordan Tarshis,Julie Hallet,Natalie G. Coburn,Natalie G. Coburn,Calvin Law,Calvin Law,Paul J. Karanicolas,Paul J. Karanicolas +10 more
TL;DR: ICS is cost-minimizing for routine use in liver resection, particularly when used for patients with a risk of transfusion of 25% or greater, especially when used by institutions considering adoption of ICS for hepatectomies.
18